| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| G9IEG7 | Cytochrome b; | CYTB; | NULL | 380 | human |
| T1Q5T0 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
| Q1ZY32 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; ndh4; | NULL | 458 | human |
| B3DE06 | Cytochrome c oxidase subunit 2; | COX2; coxII; | NULL | 227 | human |
| D6W5S0 | SMAD specific E3 ubiquitin protein ligase 1, isoform CRA_a; | SMURF1; | NULL | 582 | human |
| F2WE76 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| M1T2K8 | Coiled-coil alpha-helical rod protein 1 isoform 1; Coiled-coil alpha-helical rod protein 1 isoform 3; | CCHCR1; | XP_005272889.1;XP_005272890.1;XP_005272892.1;XP_005272893.1;XP_005275044.1;XP_005275045.1;XP_005275047.1;XP_005275048.1;XP_006725551.1;XP_006725765.1; | 782 | human |
| B3KN26 | Nicotinamide riboside kinase 1; cDNA FLJ13351 fis, clone OVARC1002156, highly similar to Nicotinamide riboside kinase 1 (EC 2.7.1.-); | NMRK1; | NULL | 106 | human |
| K0JCD0 | MHC class II antigen; | HLA-DPB1; | NULL | 258 | human |
| E5DY71 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| Q4G9L5 | Cytochrome b; | cytb; CYTB; | NULL | 380 | human |
| Q5U045 | Casein kinase 1 epsilon; Casein kinase 1, epsilon; HCG2014051, isoform CRA_a; | CSNK1E; | NP_001276841.1;NP_001885.1;NP_689407.1; | 416 | human |
| Q4GGB8 | Cytochrome b; | cytb; | NULL | 380 | human |
| M0QX66 | Pyroglutamyl-peptidase 1; | PGPEP1; | NULL | 89 | human |
| Q7GXT4 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; NADH5; | NULL | 603 | human |
| M0QYD8 | RuvB-like 2; RuvB-like 2 (E. coli), isoform CRA_c; | RUVBL2; | NULL | 44 | human |
| S5RG22 | Cytochrome P450 family 2 subfamily C polypeptide 9; | CYP2C9; | NULL | 490 | human |
| Q6T5J5 | Probable E3 ubiquitin-protein ligase TRIML2; Putative uncharacterized protein FLJ25801; Fragment; | FLJ25801; TRIML2; | NULL | 118 | human |
| G9LK66 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| Q4GW79 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | NADH2; ND2; | NULL | 347 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |